Skip to NavigationSkip to content

News

The FDA has approved AbbVie’s Mavyret tables (glecaprevir/pibrentasvir) as a treatment for hepatitis C (HCV) in children aged 12 to 17 years...
Biopharma firm Nabriva Therapeutics has revealed that its antibiotic Contepo (fosfomycin) has been rejected for review by the FDA as an injectable...
A diabetes drug may help people quit smoking, according to researchers at the University of Texas Health Science Center at Houston (UTHealth).
Gilead has announced that Robin Washington, the company’s Senior Vice President and Chief Financial Officer of more than a decade, is set to step...
A team of scientists from Britain and the United States have described a new form of dementia, according to a study published in the journal Brain.
GSK has scored approval in the US with Benlysta (belimumab) for the treatment of systemic lupus erythematosus (SLE) in paediatric patients over the...
Nearly two thirds (64%) of MPs believe the NHS should direct more resources towards prevention, over funding for new treatments, according to a...
President Donald Trump has said he will not accept money from pharmaceutical companies in the run up to the 2020 elections.
New Phase 3 data has been released by UCB Pharma on the safety of Cimzia (certolizumab pegol) in the treatment of moderate-to-severe plaque...
Scientists from Stanford University have, for the first time, developed a test for Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches